North America Heart Transplant Market
The North America Heart Transplant Market size was valued at US$ 7,252.10 Mn in 2022 and is projected to reach US$ 17,192.72 Mn by 2030, growing at a CAGR of 11.4% during 2022 - 2030.
Report Coverage
- Surgery Type: Orthotopic Heart Transplant and Heterotopic Heart Transplant
- Type: Donor Live Heart and Artificial Hearts
- End User: Hospitals, Cardiac Centers
US$ 7,252.10 Mn
Market size in 2022
US$ 17,192.72 Mn
Market Size by 2030
11.4%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Heart Transplant Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Heart Transplant Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Heart Transplant Market Regional Analysis
6.2 North America Heart Transplant Market Revenue 2020-2030 (US$ Million)
6.3 North America Heart Transplant Market Forecast Analysis
7. North America Heart Transplant Market Analysis – by Surgery Type
7.1 Orthotopic Heart Transplant and Heterotopic Heart Transplant
- 7.1.1 Overview
- 7.1.2 Orthotopic Heart Transplant and Heterotopic Heart Transplant: North America Heart Transplant Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America Heart Transplant Market Analysis – by Type
8.1 Donor Live Heart and Artificial Hearts
- 8.1.1 Overview
- 8.1.2 Donor Live Heart and Artificial Hearts: North America Heart Transplant Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America Heart Transplant Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Heart Transplant Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Cardiac Centers
- 9.2.1 Overview
- 9.2.2 Cardiac Centers: North America Heart Transplant Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America Heart Transplant Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North America Heart Transplant Market Breakdown, by Key Country, 2023 and 2030 (%)
- 10.2.1.1 North America Heart Transplant Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 US: North America Heart Transplant Market Breakdown, by Surgery Type
- 10.2.1.1.2 US: North America Heart Transplant Market Breakdown, by Type
- 10.2.1.1.3 US: North America Heart Transplant Market Breakdown, by End User
- 10.2.1.2 Canada: North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Canada: North America Heart Transplant Market Breakdown, by Surgery Type
- 10.2.1.2.2 Canada: North America Heart Transplant Market Breakdown, by Type
- 10.2.1.2.3 Canada: North America Heart Transplant Market Breakdown, by End User
- 10.2.1.3 Mexico : North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Mexico : North America Heart Transplant Market Breakdown, by Surgery Type
- 10.2.1.3.2 Mexico : North America Heart Transplant Market Breakdown, by Type
- 10.2.1.3.3 Mexico : North America Heart Transplant Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Terumo Corp
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Evaheart Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Abbott Laboratories
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 SynCardia Systems LLC
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 BiVACOR Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 BioVentrix Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Berlin Heart GmbH
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 LivaNova Plc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Jarvik Heart Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
